# Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

> **NCT01082302** · PHASE4 · COMPLETED · sponsor: **MediGene** · enrollment: 43 (actual)

## Conditions studied

- Genital Warts
- Perianal Warts

## Interventions

- **DRUG:** Polyphenon E (Veregen) 15% ointment
- **OTHER:** Green Tea Beverage with defined catechin content

## Key facts

- **NCT ID:** NCT01082302
- **Lead sponsor:** MediGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2010-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082302, "Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01082302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*